In vivo and in vitro evidence that PPARγ Ligands are antagonists of leptin signaling in breast cancer

American Journal of Pathology

Volumn 179, Issue 2, 2011, Pages 1030-1040

  Catalano, Stefania ^a   Mauro, Loredana ^a   Bonofiglio, Daniela ^a   Pellegrino, Michele ^a   Qi, Hongyan ^a   Rizza, Pietro ^a   Vizza, Donatella ^a   Bossi, Gianluca ^b   Andò, Sebastiano ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GLUCOCORTICOID RECEPTOR; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR RECEPTOR COREPRESSOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL AGGREGATION; CELL PROLIFERATION; CELL STRAIN MCF 7; FEMALE; GENE EXPRESSION; GENE REPRESSION; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; HUMANS; LEPTIN; LIGANDS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, NUDE; OBESITY; PPAR GAMMA; RECEPTORS, GLUCOCORTICOID; RECEPTORS, THYROID HORMONE; RISK FACTORS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 80052442662     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.04.026     Document Type: Article

References (49)

1. E.E. Calle, and R. Kaaks Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 2004 579 591 (Pubitemid 39025053)
2. R.T. Chlebowski, E. Aiello, and A. McTiernan Weight loss in breast cancer patient management J Clin Oncol 20 2002 1128 1143 (Pubitemid 34141858)
3. Ahima RS, Flier JS: Leptin. Annu Rev Physiol 2006, 2:413437
4. C. Garofalo, and E. Surmacz Leptin and cancer J Cell Physiol 207 2006 12 22
5. L. Vona-Davis, and D.P. Rose Adipokines as endocrine, paracrine and autocrine factors in breast cancer risk and progression Endocr Relat Cancer 14 2007 189 206 (Pubitemid 47242622)
6. S. Catalano, S. Marsico, C. Giordano, L. Mauro, P. Rizza, M.L. Panno, and S. Leptinenhances, via AP-1, expression of aromatase in the MCF-7 cell line J Biol Chem 278 2003 28668 28676 (Pubitemid 36935773)
7. L. Mauro, S. Catalano, G. Bossi, M. Pellegrino, I. Barone, S. Morales, C. Giordano, V. Bartella, I. Casaburi, and S. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression Cancer Res 67 2007 3412 3421 (Pubitemid 46724882)
8. S. Catalano, L. Mauro, S. Marsico, C. Giordano, P. Rizza, V. Rago, D. Montanaro, M. Maggiolini, M.L. Panno, and S. ó Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor α in MCF-7 cells J Biol Chem 279 2004 19908 19915 (Pubitemid 38623433)
9. B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr Rev 20 1999 649 688 (Pubitemid 30650602)
10. C.E. Quinn, P.K. Hamilton, C.J. Lockhart, and G.E. McVeigh Thiazolidinediones: effects on insulin resistance and the cardiovascular system Br J Pharmacol 153 2008 636 645 (Pubitemid 351271751)
11. P. De Vos, A.M. Lefebvre, S.G. Miller, M. Guerre-Millo, K. Wong, R. Saladin, L.G. Hamann, B. Staels, M.R. Briggs, and J. Auwerx Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ J Clin Invest 98 1996 1004 1009 (Pubitemid 26293319)
12. J. Rieusset, J. Auwerx, and H. Vidal Regulation of gene expression by activation of the peroxisome proliferator-activated receptor γ with rosiglitazone (BRL 49653) in human adipocytes Biochem Biophys Res Commun 265 1999 265 271
13. S. Goetze, A. Bungenstock, C. Czupalla, F. Eilers, P. Stawowy, U. Kintscher, C. Spencer-Hnsch, K. Graf, B. Nrnberg, R.E. Law, E. Fleck, and M. Grfe Leptin induces endothelial cell migration through Akt, which is inhibited by PPARγ-ligands Hypertension 40 2002 748 754 (Pubitemid 35278614)
14. J.I. Lee, Y.H. Paik, K.S. Lee, J.W. Lee, Y.S. Kim, S. Jeong, K.S. Kwon, D.H. Lee, H.G. Kim, Y.W. Shin, and M.A. Kim A peroxisome-proliferator activated receptor-γ ligand could regulate the expression of leptin receptor on human hepatic stellate cells Histochem Cell Biol 127 2007 495 502 (Pubitemid 46632450)
15. S. Rocchi, and J. Auwerx Peroxisome proliferator-activated receptor-γ: a versatile metabolic regulator Ann Med 31 1999 342 351 (Pubitemid 29497696)
16. Min/+ mice Nat Med 4 1998 1053 1057 (Pubitemid 28417338)
17. E. Saez, P. Tontonoz, M.C. Nelson, J.G. Alvarez, U.T. Ming, S.M. Baird, V.A. Thomazy, and R.M. Evans Activators of the nuclear receptors PPARγ enhance colon polyp formation Nat Med 4 1998 1058 1061 (Pubitemid 28417339)
18. R. Chinery, R.J. Coffey, R. Graves-Deal, S.C. Kirkland, S.C. Sanchez, W.E. Zackert, J.A. Oates, and J.D. Morrow Prostaglandin J2 and 15-deoxy-Δ 12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells Cancer Res 59 1999 2739 2746 (Pubitemid 29269124)
19. E. Elstner, C. Mller, K. Koshizuka, E.A. Williamson, D. Park, H. Asou, P. Shintaku, J.W. Said, D. Heber, and H.P. Koeffler Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice Proc Natl Acad Sci U S A 95 1998 8806 8811
20. C. Grommes, G.E. Landreth, and M.T. Heneka Antineoplastic effects of peroxisome proliferator-activated receptor γ agonists Lancet Oncol 5 2004 419 429 (Pubitemid 38878045)
21. D. Bonofiglio, S. Gabriele, S. Aquila, S. Catalano, M. Gentile, E. Middea, F. Giordano, and S. Estrogen receptor α binds to peroxisome proliferator-activated receptor (PPAR) response element and negatively interferes with PPAR γ signalling in breast cancer cells Clin Cancer Res 11 2005 6139 6147 (Pubitemid 41262940)
22. D. Bonofiglio, S. Aquila, S. Catalano, S. Gabriele, M. Belmonte, E. Middea, H. Qi, C. Morelli, M. Gentile, M. Maggiolini, and S. Peroxisome proliferator-activated receptor γ activates p53 gene promoter binding to the nuclear factor-κB sequence in human MCF7 breast cancer cells Mol Endocrinol 20 2006 3083 3092 (Pubitemid 44833557)
23. D. Bonofiglio, S. Gabriele, S. Aquila, H. Qi, M. Belmonte, S. Catalano, and S. Peroxisome proliferator-activated receptor γ activates fas ligand gene promoter inducing apoptosis in human breast cancer cells Breast Cancer Res Treat 113 2009 423 434
24. N.C. Andrews, and D.V. Faller A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells Nucleic Acids Res 19 1991 2499
25. C. Morelli, C. Garofalo, D. Sisci, S. del Rincon, S. Cascio, X. Tu, A. Vecchione, E.R. Sauter, W.H. Miller Jr, and E. Surmacz Nuclear insulin receptor substrate 1 interacts with estrogen receptor α at ERE promoters Oncogene 23 2004 7517 7526 (Pubitemid 39389693)
26. R. Sirianni, A. Chimento, R. Malivindi, I. Mazzitelli, S., and V. Pezzi Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation Cancer Res 67 2007 8368 8377 (Pubitemid 47395176)
27. L. Mauro, and E. Surmacz IGF-I receptor, cell-cell adhesion, tumor development and progression J Mol Histol 35 2004 247 253 (Pubitemid 40585310)
28. G. Sweeney Leptin signalling Cell Signal 14 2002 655 663 (Pubitemid 34518619)
29. R.S. Ahima, and S.Y. Osei Leptin signaling Physiol Behav 81 2004 223 241 (Pubitemid 38670089)
30. R.N. Cohen Nuclear receptor corepressors and PPARγ Nucl Recept Signal 4 2006 e003
31. M. Ricote, and C.K. Glass PPARs and molecular mechanisms of transrepression Biochim Biophys Acta 1771 2007 926 935 (Pubitemid 47198544)
32. S. van der Laan, and O.C. Meijer Pharmacology of glucocorticoids: beyond receptors Eur J Pharmacol 585 2008 483 491
33. K. Ronacher, K. Hadley, C. Avenant, E. Stubsrud, S.S. Simons Jr, A. Louw, and J.P. Hapgood Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction Mol Cell Endocrinol 299 2009 219 231
34. J. Zhou, R.H. Oakley, and J.A. Cidlowski DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome, gene 1) selectively inhibits transactivation but not transrepression mediated by the glucocorticoid receptor in a LXXLL-dependent manner Mol Endocrinol 22 2008 1521 1534 (Pubitemid 351920388)
35. P. Zimmet, E.J. Boyko, G.R. Collier, and M. de Courten Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players Ann N Y Acad Sci 892 1999 25 44
36. Y. Tang, S. Zheng, and A. Chen Curcumin eliminates leptin's effects on hepatic stellate cell activation via interrupting leptin signaling Endocrinology 150 2009 3011 3020
37. C.B. Kallen, and M.A. Lazar Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes Proc Natl Acad Sci U S A 93 1996 5793 5796 (Pubitemid 26191315)
38. D.W. Gong, S. Bi, R.E. Pratley, and B.D. Weintraub Genomic structure and promoter analysis of the human obese gene J Biol Chem 271 1996 3971 3974 (Pubitemid 26070491)
39. W. Chen, T. Dang, R.D. Blind, Z. Wang, C.N. Cavasotto, A.B. Hittelman, I. Rogatsky, S.K. Logan, and M.J. Garabedian Glucocorticoid receptor phosphorylation differentially affects target gene expression Mol Endocrinol 22 2008 1754 1766
40. A. Ialenti, G. Grassia, P. Di Meglio, P. Maffia, M. Di Rosa, and A. Ianaro Mechanism of the anti-inflammatory effect of thiazolidinediones: relationship with the glucocorticoid pathway Mol Pharmacol 67 2005 1620 1628 (Pubitemid 40594161)
41. M. Nie, L. Corbett, A.J. Knox, and L. Pang Differential regulation of chemokine expression by peroxisome proliferator-activated receptor γ agonists: interactions with glucocorticoids and β2-agonists J Biol Chem 280 2005 2550 2561 (Pubitemid 40189357)
42. J.M. Hall, J.F. Couse, and K.S. Korach The multifaceted mechanisms of estradiol and estrogen receptor signaling J Biol Chem 276 2001 36869 36872
43. B.S. Katzenellenbogen, and J.A. Katzenellenbogen Biomedicine: defining the "S" in SERMs Science 295 2002 2380 2381
44. S. Ghisletti, W. Huang, K. Jepsen, C. Benner, G. Hardiman, M.G. Rosenfeld, and C.K. Glass Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways Genes Dev 23 2009 681 693
45. M. Gurnell, J.M. Wentworth, M. Agostini, M. Adams, T.N. Collingwood, C. Provenzano, P.O. Browne, O. Rajanayagam, T.P. Burris, J.W. Schwabe, M.A. Lazar, and V.K. Chatterjee A dominant-negative peroxisome proliferator-activated receptor γ (PPARγ) mutant is a constitutive repressor and inhibits PPARγ-mediated adipogenesis J Biol Chem 275 2000 5754 5759 (Pubitemid 30115218)
46. Q. Wang, J.A. Blackford Jr, L.N. Song, Y. Huang, S. Cho, and S.S. Simons Jr Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors Mol Endocrinol 18 2004 1376 1395 (Pubitemid 38692177)
47. A.M. Krogsdam, C.A. Nielsen, S. Neve, D. Holst, T. Helledie, B. Thomsen, C. Bendixen, S. Mandrup, and K. Kristiansen Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation Biochem J 363 2002 157 165 (Pubitemid 34280622)
48. E. Powell, P. Kuhn, and W. Xu Nuclear receptor cofactors in PPARγ-mediated adipogenesis and adipocyte energy metabolism PPAR Res 2007 2007 53843
49. S.P. Samarasinghe, M.M. Sutanto, A.M. Danos, D.N. Johnson, M.J. Brady, and R.N. Cohen Altering PPARγ ligand selectivity impairs adipogenesis by thiazolidinediones but not hormonal inducers Obesity (Silver Spring) 17 2009 965 972